Vaccines for the prevention against the threat of MERS-CoV

First identified in 2012, Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV) is listed as a new Category C Priority Pathogen. While the high mortality of MERS-CoV infection is further intensified by potential human-to-human transmissibility, no MERS vaccines are available for human use....

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Lanying, Tai, Wanbo, Zhou, Yusen, Jiang, Shibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5097835/
https://www.ncbi.nlm.nih.gov/pubmed/26985862
http://dx.doi.org/10.1586/14760584.2016.1167603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5097835/
https://www.ncbi.nlm.nih.gov/pubmed/26985862
http://dx.doi.org/10.1586/14760584.2016.1167603

Ejemplares similares